What is Assembly Biosciences's R&D?

Assembly Biosciences (ASMB) reported R&D of $14.9M in Q1 2026.

How has Assembly Biosciences's R&D changed year-over-year?

Assembly Biosciences's R&D increased by 0.3% year-over-year, from $14.85M to $14.9M.

What is the long-term trend for Assembly Biosciences's R&D?

Over 4 years (2021 to 2025), Assembly Biosciences's R&D has grown at a -1.4% compound annual growth rate (CAGR), from $68.52M to $64.81M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Assembly Biosciences ASMB R&D

R&D at other companies

Arrowhead ResearchARWR

$173.25M+30.2%

ALN

Alnylam PharmaceuticalsALNY

$364.87M+37.6%

Avalo TherapeuticsAVTX

$14.05M+54.0%

Arbutus Biopharma CorporationABUS

$4.12M-54.0%

Vir Biotechnology, Inc.VIR

$108.92M-8.2%

Maravai LifeSciences Holdings, Inc.MRVI

$3.89M-20.4%

Other financials

Income statement

See full

Revenue$8.2M-12.8%

Operating income-$11.4M-14.4%

Net income-$9.1M-3.0%

EPS (diluted)-$0.54+53.8%

Balance sheet

See full

Cash & equivalents$31.1M+32.9%

Total debt$2.5M-17.5%

Total equity$198.6M+632%

Total assets$235.5M+138%

Cash flow

See full

Operating cash flow-$22.1M+5.7%

CapEx$19.0K—

Free cash flow-$22.1M+5.6%

Valuation

See full

Market cap$480.77M+262%

Enterprise value$452.14M+302%

P/S6.8×+2.6×

Profitability

See full

Operating margin-116.8%-26.1pp

Net margin-103.6%-22.7pp

FCF margin-150%-231pp

Returns & leverage

See full

Return on equity-36.9%-15.1pp

Debt / equity0×-0.1×

Current ratio6.6×+4.6×

Where this comes from

Reported directly by Assembly Biosciences in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Assembly Biosciences's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Assembly Biosciences's R&D?: Assembly Biosciences (ASMB) reported R&D of $14.9M in Q1 2026.
How has Assembly Biosciences's R&D changed year-over-year?: Assembly Biosciences's R&D increased by 0.3% year-over-year, from $14.85M to $14.9M.
What is the long-term trend for Assembly Biosciences's R&D?: Over 4 years (2021 to 2025), Assembly Biosciences's R&D has grown at a -1.4% compound annual growth rate (CAGR), from $68.52M to $64.81M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.